F-Star Therapeutics’ Takeover by Sino Biopharmaceutical Delayed Again
UK-based F-Star Therapeutics Inc., (NASDAQ: FSTX) revealed that there has been yet another delay to...
Finance
Everlife Biomed Raises Pre-Series A+ Funding for Immune Exemption Platform
Beijing-based Everlife Biomed reportedly raised “tens of millions” of renminbi in a pre-Series A+ financing...
Lavamed Secures USD 40M in Angel and Series A Financing Rounds
Lavamed, a high-end neurointervention device maker based in Suzhou, has successively closed angel and Series...
Tsingke Biotech Secures RMB 400M Series B Financing for Expansion
Beijing Tsingke Biotech Co., Ltd. a gene synthesis company based in Beijing, reportedly raised RMB...
SAFE Raises RMB 500M in Series D Financing to Expand CRO Services
Serve Accurate Faithful Evaluation (SAFE), a contract research organization (CRO) co-founded by the Chinese Academy...
Yifan Pharma Transfers F-627 Distribution Rights in Germany to Apogepha
China-based Yifan Pharmaceutical Co., Ltd (SHE: 002019) announced the transfer of exclusive distribution rights in...
Yifan Pharmaceutical Licenses F-627 to Acrotech for US Distribution
China-based Yifan Pharmaceutical Co., Ltd (SHE: 002019) announced the establishment of a licensing agreement with...
Nans Tech Secures Series A Funding for Brain Dysfunction Digital Therapies
Nans Tech, a brain dysfunction digital therapy developer based in Hangzhou, reportedly raised “tens of...
Henan Celnovte Biotechnology Raises RMB 100M in New Financing Round
China-based Henan Celnovte Biotechnology Co., Ltd, a tumor in vitro diagnostic reagents (IVDs) and instruments...
Hangzhou Polymed Biopharmaceuticals Raises Funds for Clinical Pipeline
China-based Hangzhou Polymed Biopharmaceuticals has reportedly completed a Pre-Series A+ financing round, raising an undisclosed...
Fosun Pharma’s Gland Pharma to Acquire French CDMO Cenexi for EUR 120 Million
Shanghai Fosun Pharmaceutical Group Co (SHA: 600196) announced that its India-based subsidiary, Gland Pharma Ltd...
Zhejiang Jiuzhou Pharma to Raise RMB 2.5 Billion via Private Placement
China-based Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA: 603456) has received approval from the China Securities...
JancsiTech Raises Tens of Millions in Angel Round Led by Yuanbio Venture Capital
JancsiTech, a precision nuclear medicine specialist based in Shenzhen, has reportedly raised “tens of millions”...
Full-Life Technologies Acquires Focus-X Therapeutics to Expand Pipeline
Shanghai-headquartered Full-Life Technologies Ltd has announced the acquisition of New Jersey-based Focus-X Therapeutics. The move...
Trinomab Biotech Raises RMB 750 Million in Pre-IPO Financing Round
China-based Trinomab Biotech Co., Ltd reportedly raised RMB 750 million (USD 104.5 million) in a...
ZSHK Laboratories Raises RMB 100 Million in Series B Financing Round
China-based pre-clinical Contract Research Organization (CRO) ZSHK Laboratories Limited has reportedly raised close to RMB...
Anyeep Raises RMB 100 Million in Series A Financing for Mass Spectrometry Development
Anyeep, a Suzhou-based developer of mass spectrometers, has reportedly raised close to RMB 100 million...
Xiling Lab Raises RMB 100 Million for ADC Development and IND Filing
Xiling Lab, a Chengdu-based drug developer specializing in catalytic synthesis technology, has reportedly raised close...
PrimeLink Bio Raises Funds for ADC Development and R&D Expansion
Shenzhen-based drug developer PrimeLink Bio has reportedly raised “hundreds of millions” of renminbi in a...
Saint Medical Raises Pre-Series B Funding for Structural Heart Disease Solutions
Saint Medical Technology, a Nanjing-based medical device maker specializing in valvular disease solutions, has reportedly...